IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
A. Berger, Elinor Gigi, Lana Kupershmidt, Zohar Meir, Nancy Gavert, Yaara Zwang, Amir Pri-Or, Shlomit Gilad, Uzi Harush, Izhak Haviv, Salomon M. Stemmer, Galia Blum, Emmanuelle Merquiol, Mariya Mardamshina, Sivan Kaminski Strauss, Gilgi Friedlander, Jair Bar, Iris Kamer, Yitzhak Reizel, Tamar Geiger, Yitzhak Pilpel, Yishai Levin, Amos Tanay, Baruch Barzel, Hadas Reuveni, Ravid Straussman
Topics & Concepts
Epidermal growth factor receptorIn vivoIRS1PhosphorylationIn vitroCancerCancer researchCancer cellSerineBiologyCell biologyBiochemistryInsulin receptorGeneticsEndocrinologyInsulinInsulin resistanceLung Cancer Treatments and MutationsCancer Genomics and DiagnosticsBioinformatics and Genomic Networks